BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System

Recognition from Vizient validates CentroVena One™ as a breakthrough innovation designed to simplify central line insertion and enhance patient and clinician safety FRANKLIN LAKES, N.J., June 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD® CentroVena One™ Insertion System has been awarded an Innovative Technology contract from Vizient®, the nation's largest provider-driven healthcare performance improvement company.

PRNewsWire • 8 hours ago

3 Excellent Dividend Stocks to Buy on the Dip

Despite facing some headwinds, these three companies still have strong long-term prospects. All three have raised their payouts for more than 50 consecutive years.

The Motley Fool • Jun 22, 2026

Rep Thomas Kean just filed 4 new congressional stock trades

Representative Thomas H. Kean Jr, a Republican from New Jersey who sits on the House Energy and Commerce Committee, has disclosed four new congressional stock trades.

Finbold • Jun 19, 2026

The Healthcare M&A Wave

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

Forbes • Jun 17, 2026

Here's Why You Should Retain BDX Stock in Your Portfolio Now

Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.

Zacks Investment Research • Jun 16, 2026

Jim Cramer: Buy Becton Dickinson, This Tech Stock Has Too High Valuation

On CNBC's “Mad Money Lightning Round,” Jim Cramer said about JFrog Ltd (NASDAQ:FROG) that the multiple "is too high," although software development "is a good business." The stock has risen more than 40% year-to-date, against the backdrop of exploding demand for AI coding agents and LLMs (large language models).

Benzinga • Jun 4, 2026

BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care

BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.

Zacks Investment Research • May 22, 2026

BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System

New laser system is designed to help urology teams enhance efficiency, versatility, and procedural workflow across stone management and soft tissue procedures. FRANKLIN LAKES, N.J.

PRNewsWire • May 21, 2026

Peter Menziuso Named EVP and President, BD Interventional

FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1.

PRNewsWire • May 18, 2026

These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More

With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will tariffs, discarded trade deals, and frayed alliances help or hurt the market?

Investopedia • May 18, 2026